Showing results (141-150 of 703) with videos related to

Sort By:
Pageof 71
American Journal of Preventive Cardiology|July 6, 2026
Impact of air pollution exposure on chronic kidney disease and type 2 diabetes: A FIDELITY analysisSadeer Al-Kindi, Zhuo Chen, Jean-Eudes Dazard, et al.
American Journal of Preventive Cardiology|August 5, 2022
Socioeconomic status, cardiovascular risk profile, and premature coronary heart diseaseSafi U Khan, Ryan T Nguyen, Zulqarnain Javed, et al.
American Journal of Preventive Cardiology|August 4, 2022
Associations between cumulative social risk, psychosocial risk, and ideal cardiovascular health: Insights from the HeartSCORE studyJulia Berkowitz, Vishal Khetpal, Justin B Echouffo-Tcheugui, et al.
American Journal of Preventive Cardiology|August 10, 2021
Erratum to 'Lipid Treatment and Goal Attainment Characteristics among Persons with Atherosclerotic Cardiovascular Disease in the United States' [American Journal of Preventive Cardiology 1C (2020) 100010]Alexa C Klimchak, Miraj Y Patel, Şerban R Iorga, et al.
American Journal of Preventive Cardiology|August 10, 2021
Corrigendum to ``Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction'' [American Journal of Preventive Cardiology, Volume 4, 2020, Pages 1-12]Geeta Sikand, Tracy Severson
American Journal of Preventive Cardiology|September 5, 2022
GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, StrokeKayla A Riggs, Parag H Joshi, Amit Khera, et al.
American Journal of Preventive Cardiology|September 12, 2022
Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technologyAamir Javaid, Fawzi Zghyer, Chang Kim, et al.
American Journal of Preventive Cardiology|December 24, 2021
Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular diseaseGlenn T Gobbel, Michael E Matheny, Ruth R Reeves, et al.
American Journal of Preventive Cardiology|December 10, 2021
Association between diet quality and incident cardiovascular disease stratified by body mass indexNathan W Kong, Hongyan Ning, Victor W Zhong, et al.
American Journal of Preventive Cardiology|August 30, 2022
Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver diseasePeter P Toth, Gregory G Schwartz, Stephen J Nicholls, et al.
Pageof 71